摘要
目的:检测再生障碍性贫血(AA)和骨髓增生异常综合征(MDS)患者CD34+细胞占骨髓单个核细胞(BMMNC)的比率及其表面粒细胞集落刺激因子受体(G-CSFR)的表达率。方法:用流式细胞术(FCM)检测13例AA、22例MDS及12例非血液病患者CD34+细胞占BMMNC的比率及其表面G-CSFR的表达率。结果:AA组与对照组、AA组与MDS组、MDS-难治性贫血(RA)组与难治性贫血伴原始细胞增多(RAEB)组BMMNC中CD34+细胞的比率比较差异有统计学意义(P<0.05),但G-CSFR的表达率差异无统计学意义(P>0.05)。多数重型AA(SAA)患者(3/4)及少数慢性AA(CAA)患者(1/9)BMMNC中的CD34+细胞少于0.1%。多数G-CSFR表达率低(<14%)的患者(7/9)外周血中性粒细胞减少;而表达率正常(14.0%~28.9%)的患者(1/6)很少见;表达率高(>28.9%)的患者(3/7)也可存在中性粒细胞减少。结论:造血干细胞减少是AA的主要发病机制之一,其表面G-CSFR的表达率不是影响AA的主要因素;MDS患者CD34+细胞比率升高是一个预后不良的指标,G-CSFR的检测可部分解释MDS患者外周血中性粒细胞减少的原因。
Objective:To detect the ratio of CD34 positive cells in bone marrow mononuclear cells and the expressive rate of granulocyte colony-stimulating factor receptor(G-CSFR) on CD34 positive cells in bone marrow of the patients with aplastic anemia (AA) and myelodysplastic syndrome(MDS). Method:The ratio of CD34 positive cells in bone marrow mononuclear cells and the expressive rate of C,-CSFR on cells of 13 AA patients, 22 MDS patients and 12 normal subjects were detected by flow cytometry(FCM). Result:There was significant difference according to the ratio of CD34 positive cells in mononuclear cells of bone marrow between AA group and control group, AA group and MDS group, MDS-RA group and MDS-RAEB group (P〈0.05) but there was no significant difference according to the expressive rate of G-CSFR on CD34 positive cells. The ratio of CD34 positive cells in mononuclear cells of bone marrow was less than 0.1% in the majority of SAA patients(3/4) while it was seldom less than 0.1% in CAA patients. Most MDS patients(7/9) with low G-CSFR expression had neutropenia of the peripheral blood. Neutropenia was less common in the normal expression group(1/6), but also occurred in the high expression group(3/7). Conclusion:The reduction of hematopoletic stem cells is one of the principal pathogenesis of AA , but the expressive rate of G-CSFR on CD34 positive cells in bone marrow isn't a main factor. The in- creased ratio of CD34 positive cells in bone marrow of MDS patients may be a poor prognostic indicator. The determination of G-CSFR on CD34 positive cells in bone marrow can partly explain why MDS patients have neutropenia of the peripheral blood.
出处
《临床血液学杂志》
CAS
2007年第6期323-325,共3页
Journal of Clinical Hematology